ENVALITH
株式会社コスモス薬品 logo

COSMOS Pharmaceutical Corporation

3349Prime MarketRetail Trade

株式会社コスモス薬品 logo
COSMOS Pharmaceutical Corporation3349

Governance

Company with an Audit and Supervisory Committee (transitioned in 2015). The Board of Directors comprises 6 members in total: 3 internal directors and 3 directors serving as Audit and Supervisory Committee members (2 of whom are outside directors). A "Nomination and Compensation Committee," in which independent outside directors constitute a majority, has been established as an advisory body to the Board of Directors, ensuring objectivity and transparency in the nomination and compensation processes.

Outside Director Ratio

33.3%

Nomination Committee

Established

Compensation Committee

Established

Risk Management

The President and Representative Director serves as the overall officer in charge, and the Director responsible for administrative divisions serves as the officer in charge of overall risk management, thereby managing risks across the entire company. The Company has established a standing Compliance Committee and internal whistleblowing contact point, and has developed a framework whereby, in the event of an unforeseen incident, the President and Representative Director organizes a crisis management team to respond. With respect to climate change risk, the Corporate Planning Department works in coordination with relevant departments to identify and assess risks and opportunities across the supply chain.

Shareholder Returns

Progressive dividend is the basic policy, achieving stable and continuous shareholder returns. Annual dividend for FY2026 (ending May 2026) is ¥82 per share (interim ¥37.5 + year-end ¥44.5), with a payout ratio of 20.3%. FY2027 (ending May 2027) is planned at ¥84 (up ¥2 year on year).

Dividend Policy

The policy is to achieve stable and continuous profit distribution to shareholders through dividends based fundamentally on a progressive dividend policy, while securing sufficient internal reserves to strengthen the management foundation and allocate to appropriate reinvestment. The annual dividend for FY2026 (ending May 2026) is ¥82 per share (interim ¥37.5 + year-end ¥44.5), with a payout ratio of 20.3% and total dividends of ¥6,499 million. For FY2027 (ending May 2027), an interim dividend of ¥42 and a year-end dividend of ¥42, totaling ¥84 per share (up ¥2 year on year), is planned, with an expected payout ratio of 21.7%.

Dividend

Paying

Share Buyback

None

Shareholder Benefits

None

ESG

Discloses climate change response in line with the four TCFD pillars. The company has set a target of reducing CO2 emissions per store by 50% by FY2030 compared to FY2013 levels, with FY2024 actual results of 194.8t-CO2 (a 48.2% reduction), approaching the target achievement level. On the human capital front, the company adopts a personnel system that emphasizes motivation regardless of educational background, age, or gender, and advocates a

Last updated: August 28, 2025